Fortrea Holdings/$FTRE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Fortrea Holdings
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Ticker
$FTRE
Sector
Health
Primary listing
Employees
15,810
Headquarters
Website
Fortrea Holdings Metrics
BasicAdvanced
$657M
-
-$11.40
1.80
-
Price and volume
Market cap
$657M
Beta
1.8
52-week high
$25.74
52-week low
$3.97
Average daily volume
2.3M
Financial strength
Current ratio
1.019
Quick ratio
0.871
Long term debt to equity
195.961
Total debt to equity
210.862
Interest coverage (TTM)
-0.81%
Profitability
EBITDA (TTM)
8.2
Gross margin (TTM)
19.73%
Net profit margin (TTM)
-37.57%
Operating margin (TTM)
-2.67%
Effective tax rate (TTM)
-0.08%
Revenue per employee (TTM)
$170,000
Management effectiveness
Return on assets (TTM)
-1.42%
Return on equity (TTM)
-100.49%
Valuation
Price to revenue (TTM)
0.239
Price to book
1.12
Price to tangible book (TTM)
-0.64
Price to free cash flow (TTM)
-6.324
Free cash flow yield (TTM)
-15.81%
Free cash flow per share (TTM)
-1.145
Growth
Revenue change (TTM)
-0.53%
Earnings per share change (TTM)
229.26%
What the Analysts think about Fortrea Holdings
Analyst ratings (Buy, Hold, Sell) for Fortrea Holdings stock.
Fortrea Holdings Financial Performance
Revenues and expenses
Fortrea Holdings Earnings Performance
Company profitability
Fortrea Holdings News
AllArticlesVideos
FTRE Deadline: Rosen Law Firm Urges Fortrea Holdings, Inc. (NASDAQ: FTRE) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Business Wire·2 weeks ago
FTRE INVESTOR ALERT: Kirby McInerney LLP Notifies Fortrea Holdings Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
Business Wire·4 weeks ago
Fortrea Holdings Inc. (FTRE) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of August 1, 2025 Deadline
Accesswire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Fortrea Holdings stock?
Fortrea Holdings (FTRE) has a market cap of $657M as of August 09, 2025.
What is the P/E ratio for Fortrea Holdings stock?
The price to earnings (P/E) ratio for Fortrea Holdings (FTRE) stock is 0 as of August 09, 2025.
Does Fortrea Holdings stock pay dividends?
No, Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders as of August 09, 2025.
When is the next Fortrea Holdings dividend payment date?
Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders.
What is the beta indicator for Fortrea Holdings?
Fortrea Holdings (FTRE) has a beta rating of 1.8. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.